Search results for "Half-Life"

showing 10 items of 108 documents

Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study

2016

Introduction Pharmacokinetic (PK) studies on recombinant FIX concentrate, Nonacog alpha, were conducted with different sampling time designs which gave rise to not complete and homogenous outcomes. In addition, patient's FIX genotype/PK relationship has never been investigated. Aim Investigate how different sampling times may affect PK parameters and try to find a FIX genotype/PK relationship. Patients and Methods A cohort pharmacokinetic, Nonacog Alpha single-dose, open-label, non-comparative study was conducted in eight Comprehensive Care Haemophilia Centres in Italy. Seventeen previously treated moderate or severe haemophilia B patients were enrolled. Factors IX:C one-stage clotting assa…

Malemedicine.medical_specialtyGenotypeMutation MissensePharmacokinetic030204 cardiovascular system & hematologyPharmacologyHaemophiliaGastroenterologyHemophilia BDrug Administration ScheduleCohort StudiesFactor IX03 medical and health sciences0302 clinical medicinePharmacokineticsDNA Recombinant proteinInternal medicineHaemophilia BGenotypemedicineHumansHaemophilia BGenetics (clinical)Volume of distributionClotting factorbusiness.industryCoagulantsArea under the curveGeneral MedicineHematologymedicine.diseaseRecombinant ProteinsItalyROC CurveCodon NonsenseArea Under Curvebusinesspharmacokinetics030215 immunologyBlood samplingHalf-Life
researchProduct

Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion.

2014

Background Bupropion is a dopamine and norepinephrine reuptake inhibitor approved for the treatment of depression and smoking cessation. According to the recently published reviews, it is a candidate for therapeutic drug monitoring (TDM) to improve therapeutic outcomes and reduce risks of intolerability or intoxication. In practice, however, the use of TDM is limited due to the chemical instability of bupropion. This investigation sought to determine if the major, active, and chemically stable metabolite 4-hydroxybupropion is a suitable measure to guide antidepressant drug therapy with bupropion. Methods 4-Hydroxybupropion serum levels were measured using a newly developed and validated hig…

Malemedicine.medical_specialtyUrologyNorepinephrine reuptake inhibitorPharmacokineticsmedicineHumansPharmacology (medical)BupropionChromatography High Pressure LiquidRetrospective StudiesPharmacologyBupropionDepressive Disordermedicine.diagnostic_testbusiness.industryTherapeutic effectHydroxybupropionMiddle AgedTherapeutic drug monitoringArea Under CurveClinical Global ImpressionAntidepressantAntidepressive Agents Second-GenerationFemalebusinessmedicine.drugHalf-LifeTherapeutic drug monitoring
researchProduct

Tailoring the stealth properties of biocompatible polysaccharide nanocontainers.

2014

Fundamental development of a biocompatible and degradable nanocarrier platform based on hydroxyethyl starch (HES) is reported. HES is a derivative of starch and possesses both high biocompatibility and improved stability against enzymatic degradation; it is used to prepare nanocapsules via the polyaddition reaction at the interface of water nanodroplets dispersed in an organic miniemulsion. The synthesized hollow nanocapsules can be loaded with hydrophilic guests in its aqueous core, tuned in size, chemically functionalized in various pathways, and show high shelf life stability. The surface of the HES nanocapsules is further functionalized with poly(ethylene glycol) via different chemistri…

Materials scienceBiocompatibilityBiophysicsBioengineeringNanotechnologyBiocompatible MaterialsNanocapsulesPolyethylene GlycolsBiomaterialsHydroxyethyl Starch Derivativeschemistry.chemical_compoundNanocapsulesCyclohexanesPolysaccharidesPolymer chemistryMaterials TestingLeukocytesAnimalsHumansTissue DistributionDrug CarriersMice Inbred BALB CAqueous solutionWaterFlow CytometryMiniemulsionchemistryMechanics of MaterialsCeramics and CompositesPEGylationSurface modificationFemaleAdsorptionNanocarriersEthylene glycolHalf-LifeBiomaterials
researchProduct

Scandium-44: Benefits of a Long-Lived PET Radionuclide Available from the 44Ti/44Sc Generator System

2011

(44)Ti/(44)Sc radionuclide generators are of interest for molecular imaging. The 3.97 hours half-life of (44)Sc and its high positron branching of 94.27% may stimulate the application of (44)Sc-labeled PET radiopharmaceuticals. This review describes the current status of (44)Ti production, (44)Ti/(44)Sc radionuclide generator development, post-processing of generator eluates towards medical application, identification of ligands adequate to Sc(III) co-ordination chemistry, proof-of-principle labeling of (44)Sc-DOTA-octreotides, investigation of in vitro and in vivo parameters, and initial applications for molecular imaging - both in small animals and humans.

Materials scienceTransplantation HeterologousMice Nudechemistry.chemical_elementHeterocyclic Compounds 1-RingMicePositronDrug StabilityNickelNuclear ReactorsmedicineAnimalsHumansRadiology Nuclear Medicine and imagingCation Exchange ResinsScandiumChelating AgentsMice nudeRadioisotopesTitaniumPharmacologyRadionuclidemedicine.diagnostic_testRadionuclide GeneratorsLiver NeoplasmsNeoplasms ExperimentalTransplantationchemistryPositron emission tomographyPositron-Emission TomographyPuromycinAdsorptionRadiopharmaceuticalsRadionuclide GeneratorMolecular imagingScandiumHalf-LifeNuclear chemistryCurrent Radiopharmaceuticals
researchProduct

Bioaccumulation of emerging contaminants in mussel (Mytilus galloprovincialis): Influence of microplastics

2021

Coastal environments are heavily influenced by human activities. Chemical substances considered as emerging contaminants (ECs) are one of the most important indicators of the anthropic influence on the environment, and they have recently shown to interact with microplastics (MPs). Mussels are suitable for in-lab bioacumulation studies providing insight about the occurrence and fate of contaminants in the organisms. In this study, bioacummulation of 20 chemical substances catalogued as ECs, including pharmaceuticals and personal care products (PPCPs), pesticides, and perfluoroalkyl substances (PFASs) in Mytilus galloprovincialis was assessed, with or without the influence of the presence of …

Microplasticsanimal structuresEnvironmental EngineeringMicroplasticsBioconcentrationEnvironmental impact of pharmaceuticals and personal care productschemistry.chemical_compoundTandem Mass SpectrometryPFASsBioconcentration factorAnimalsHumansEnvironmental ChemistryPesticidesWaste Management and DisposalMytilusbiologyChemistryMusselPesticideKinetic modelbiology.organism_classificationBioaccumulationPollutionHalf-lifeMytilusChlorpyrifosEnvironmental chemistryBioaccumulationPharmaceuticalsPlasticsWater Pollutants Chemical
researchProduct

The beta-decay half-life of 48 130 Cd82 and its importance for astrophysicalr-process scenarios

1986

The s-decay half-life of130Cd has been measured and its importance as N=82 ‘waiting-point’ nucleus for astrophysical rapid neutron capture (r−) process scenarios is discussed.

Nuclear physicsPhysicsNuclear and High Energy PhysicsNeutron capturemedicine.anatomical_structureScientific methodNuclear TheorymedicineHalf-lifeNuclear fusionNuclear ExperimentBeta decayNucleusZeitschrift f�r Physik A Atomic Nuclei
researchProduct

Half-life measurements for neutron-rich Tc, Ru, Rh, and Pd isotopes. Identification of the new isotopesTc111,Ru113, andRh113

1988

The decays of three new neutron-rich nuclides $^{111}\mathrm{Tc}$, $^{113}\mathrm{Ru}$, and $^{113}\mathrm{Rh}$ have been observed at an on-line isotope separator facility. In addition, the beta decays of several other n-rich isotopes with Ag100 have been studied for the first time. The new half-lives reported in this work include: $^{111}\mathrm{Tc}$ [${T}_{1/2}$=0.30(3) s], $^{111}\mathrm{Ru}$ [2.12(7) s], $^{112}\mathrm{Ru}$ [1.75(7) s], $^{113}\mathrm{Ru}$ [0.80(10) s], $^{113}\mathrm{Rh}$ [2.72(22) s], and $^{118}\mathrm{Pd}$ [2.24(17) s]. In general, these results support the microscopic theoretical half-life predictions below Z=50.

Nuclear physicsPhysicsNuclear reactionNuclear and High Energy PhysicsCrystallographyIsotopelawDouble beta decayHalf-lifeNeutronIsotope separationlaw.inventionPhysical Review C
researchProduct

Heavy isotopes of actinium: 229Ac, 230Ac, 231Ac and 232Ac

1973

Abstract By irradiation of 232Th with 150-MeV bremsstrahlung and with 14-MeV neutrons, three new neutron-rich isotopes of actinium, 230Ac, 231Ac and 232Ac, were produced and identified and the previously reported isotope, 229Ac, was confirmed. The actinium isotopes were chemically isolated by a fast procedure based on elution with α-hydroxyisobutyric acid from cation exchange resins. For 229Ac, a half-life of 62·7 ± 0·5 min and a β-ray energy of 1·14 ± 0·15 MeV were found; 35 γ-rays were observed, the strongest ones with the following energies and relative intensities: 135·3(34), 146·4(35), 164·6(100), 252·2(24), 261·9(39), 317·0(23), 539·9(20), 569·1(91), and 605·2 keV(23). For 230Ac, a ha…

Nuclear reactionActiniumIsotopes of actiniumPolymers and PlasticsIsotopeChemistryRadiochemistryMaterials ChemistryBremsstrahlungHalf-lifechemistry.chemical_elementIrradiationIsotopes of thoriumJournal of Inorganic and Nuclear Chemistry
researchProduct

Nuclear structure of (231)Ac

2008

The low-energy structure of 231Ac has been investigated by means of gamma ray spectroscopy following the beta-decay of 231Ra. Multipolarities of 28 transitions have been established by measuring conversion electrons with a mini-orange electron spectrometer. The decay scheme of 231Ra --> 231Ac has been constructed for the first time. The Advanced Time Delayed beta-gamma-gamma(t) method has been used to measure the half-lives of five levels. The moderately fast B(E1) transition rates derived suggest that the octupole effects, albeit weak, are still present in this exotic nucleus. The low-energy structure of 231 Ac has been investigated by means of γ ray spectroscopy following the β − decay of…

Nuclear reactionPhysicsNuclear and High Energy PhysicsDecay schemeNuclear structureHalf-lifeFísicaElectronNuclear physicsGamma spectroscopyNuclear Physics - ExperimentAtomic physicsSpectroscopyRadioactive decay
researchProduct

Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer

2017

Background: Various trivalent radiometals are well suited for labeling of DOTA-conjugated variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The DOTA-conjugate PSMA-617 has proven high potential in PSMA radioligand therapy (PSMA-RLT) of prostate cancer as well as PET imaging when labeled with lutetium-177 and gallium-68 respectively. Considering the relatively short physical half-life of gallium-68 this positron emitter precludes prolonged acquisition periods, as required for pre-therapeutic dosimetry or intraoperative applications. In this context, the positron emitter scandium-44 is an attractive alternative for PET imaging. We report the synthesis of [44Sc…

OncologyMalemedicine.medical_specialtytheranostics.Medicine (miscellaneous)Context (language use)SpleenGallium RadioisotopesLutetiumurologic and male genital diseases030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancerHeterocyclic Compounds 1-Ring0302 clinical medicineInternal medicinePositron Emission Tomography Computed TomographyLNCaPmedicineDosimetryHumansRadiometryPharmacology Toxicology and Pharmaceutics (miscellaneous)AgedRadioisotopesUrinary bladderChemistrybusiness.industryDipeptidesProstate-Specific Antigenmedicine.diseaseprostate cancerPSMA-617scandium-44Small intestineProstatic Neoplasms Castration-Resistantmedicine.anatomical_structurePET030220 oncology & carcinogenesisAbsorbed doseRadiopharmaceuticalsNuclear medicinebusinessScandiumResearch PaperHalf-LifeTheranostics
researchProduct